The Silent Crisis: Rethinking Men’s Health at Work
Not a member and interested in attending? Contact Emily Commer!
Men are less likely to seek preventive care or undergo cancer screenings—putting them at higher risk for serious illness and premature death. These gaps have implications for employers, driving higher healthcare costs, absenteeism, and avoidable claims.
Join the NEBGH/MSK Direct fireside chat with Dr. Robert Sidlow from Memorial Sloan Kettering Cancer Center (MSK) for a practical discussion on men’s health and cancer screening. Learn what’s driving these disparities, the latest in cancer screening for men, and how employers can take action to support early detection and better outcomes.
MSK Direct is a cancer benefits solution that expands and accelerates access to the lifesaving discoveries and subspecialized expertise of Memorial Sloan Kettering Cancer Center (MSK). With a singular focus on cancer, we provide support at every stage of the cancer journey and deliver superior outcomes.
Connect with MSK Direct to learn more.
Speakers
Robert Sidlow, MD, MBA, FACP
Dr. Sidlow is a board-certified internal medicine specialist and is certified in cancer genomic risk assessment. His clinical work at MSK focuses on four main areas: perioperative consultative medicine, managing the medical complications of cancer treatment, diagnostic evaluations of patients with a suspicion of cancer, and evaluation and management of men with inherited genomic risk, such as BRCA mutations.
Dr. Sidlow has served in a variety of leadership roles, including Head of the Division of Survivorship and Supportive Care at MSK, and Deputy Chief Medical Officer and Vice Chairman of Medicine at Jacobi Medical Center/ Albert Einstein College of Medicine.
Dr. Sidlow received his Doctor of Medicine from Columbia University College of Physicians and Surgeons and his Master of Business from University of Massachusetts Isenberg School of Management. He completed his residency at Mount Sinai Hospital and has board certifications in Internal Medicine and Hospice and Palliative Medicine.
Dr. Mark Cunningham-Hill - Medical Director
Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of social, cultural and racial determinants of health.
Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.
Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.